3862 results for «644»

Filter By

3862 results

Rapid-fire - TAVI concomitant with CAD

17 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.

New possibilities in TEER

18 Feb 2024 – From PCR Tokyo Valves 2024

Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...

New possibilities in

Selection of the 2024 best clinical cases

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding clinical cases from PCR Tokyo Valves 2024, including a nightmare case with bicuspid aortic valve, pharmaco-invasive management of mechanical valve thrombus with cardiogenic shock, and a TAVR-in-TAVR challenge.

Rapid-fire - Tricuspid valve interventions in various situations

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!

Selection of the 2024 best abstracts

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire

16 May 2024 – From EuroPCR 2024

Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guide

Targeting inflammation in AMI: a debate

14 May 2024 – From EuroPCR 2024

Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.

Targeting inflammation in AMI: a debate

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

15 May 2024 – From EuroPCR 2024

This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

Left main and complex bifurcation stenting

14 May 2024 – From EuroPCR 2024

Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...

Left main and complex bifurcation stenting

Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions

16 May 2024 – From EuroPCR 2024

Explore this EuroPCR 2024 session for a comprehensive understanding of the imaging pathway in transcatheter tricuspid valve interventions, including diagnosis, therapy, and post-procedural follow-up, discover innovative, transformative imaging techniques such as 4D intracardiac echocardiography and dual-source photon-counting CT, and learn how these innovations can be applied in...

Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions

Relief for the unrelievable: the role of the Reducer for refractory angina

15 May 2024 – From EuroPCR 2024

Explore the incidence and impact of refractory angina, observe a real-life Reducer implantation procedure with step-by-step analysis and discussions, gain insight into the coronary sinus mechanism of action and implantation techniques, grasp the indications for the Reducer, and review available clinical data in this session.

Relief for the unrelievable, the role of the Reducer for refractory angina

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

15 May 2024 – From EuroPCR 2024

Watch this session to gain insights into the clinical evidence of mitral TEER therapy for the Asian population, learn techniques for implanting a MitraClip in patients with challenging anatomy, and understand how to use the four clip sizes for optimal outcomes. The session also covers educational...

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

Heterotopic tricuspid valves: to who, when and how?

15 May 2024 – From EuroPCR 2024

Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...

Heterotopic tricuspid valves: to who, when and how?

DCB PCI in restenosis and de novo lesions

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...

DCB PCI in restenosis and de novo lesions

Identification and treatment of (sub)clinical transcatheter valve thrombosis

16 May 2024 – From EuroPCR 2024

This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...

Identification and treatment of (sub)clinical transcatheter valve thrombosis

Technical pearls in CTO PCI

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the technical pearls and innovative approaches in the management of chronic total occlusions (CTO) during percutaneous coronary interventions. Attendees will have the opportunity to explore various strategies, including the use...

Technical pearls in CTO PCI
Didn’t find what you were looking for?